PARP Inhibitors in Breast Cancer: Why, How, and When?

Affiliations

• ¹ Experimental Medical Oncology, Istituto Tumori G. Paolo II, IRCCS, Bari, Italy.
• ² Weill Cornell Breast Center, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY, USA.
• ³ Department of Surgery, Oncology and Gastroenterology, University of Padova, Padua, Italy.
• ⁴ Division of Medical Oncology 2, Istituto Oncologico Veneto IRCCS, Padua, Italy.
• ⁵ Department of Breast Tumors, Cancer Institute 'Ion Chiricuta', Cluj-Napoca, Romania.
• ⁶ Breast Cancer Unit, American Hospital of Paris, Neuilly-sur-Seine, France.